Neuropeptides and human sleep

Sleep

Volumn 20, Issue 11, 1997, Pages 1038-1052

  Steiger, Axel ^a   Holsboer, Florian ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Aging; Depression; HPA system; Peptides; Sleep; Somatotropic system

Indexed keywords

NEUROPEPTIDE;

AGING; DEPRESSION; ELECTROENCEPHALOGRAM; HORMONE RELEASE; HUMAN; PRIORITY JOURNAL; REVIEW; SLEEP;

AGING; DEPRESSION; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NEUROPEPTIDES; PITUITARY-ADRENAL SYSTEM; SLEEP, REM;

EID: 0031464872     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (141)

1. Obál F Jr, Opp M, Sary G, Krueger JM. Endocrine mechanisms in sleep regulation. In: Inoué S, Krueger JM, eds. Endogenous sleep factors. The Hague: SPB Academic Publishing, 1990: 109-20.
2. Quabbe HJ, Schilling E, Helge H. Pattern of growth hormone secretion during a 24-hour fast in normal adults. J Clin Endocrinol Metab 1966;26:1173-77.
3. Takahashi Y, Kipnis DM, Daughaday WH. Growth hormone secretion during sleep. J Clin Invest 1968;47:2079-90.
4. Sassin JF, Parker DC, Mace JW, Gotlin RW, Johnson LC, Rossman LG. Human growth hormone release: relation to slow-wave sleep and sleep-waking cycles. Science 1969;165:513-5.
5. Weitzman ED. Circadian rhythms and episodic hormone secretion in man. Annu Rev Med 1976;27:225-43.
6. Ehlers CL, Reed TK, Henriksen SJ. Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology 1986;42:467-74.
7. Nistico G, De Sarro GB, Bagetta G, Muller EE. Behavioural and electrocortical spectrum power effects of growth hormone releasing factor in rats. Neuropharmacology 1987;26:75-8.
8. Obál F Jr, Alföldi P, Cady AB, Johannsen L, Sary G, Krueger JM. Growth hormone-releasing factor enhances sleep in rats and rabbits. Am J Physiol 1988;255:R310-6.
9. Opp M, Obál F Jr, Krueger JM. Corticotropin-releasing factor attenuates interleukin 1-induced sleep and fever in rabbits. Am J Physiol 1989;257:R528-35.
10. Krueger JM, Obál F Jr. Growth hormone-releasing hormone and interleukin-1 in sleep regulation. FASEB J 1993;7:645-52.
11. Dunn AJ, Berridge CW. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Brain Res Rev 1990;15:71-100.
12. Holsboer F, von Bardeleben U, Steiger A. Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man. Neuroendocrinology 1988;48:32-8.
13. Holsboer F. Neuroendocrinology of affective disorders. In: Bloom FE, Kupfer DJ, eds. Neuropsychopharmacology. 4th generation of progress. New York: Raven Press, 1995:957-70.
14. Tsuchiyama Y, Uchimura N, Sakamoto T, Maeda H, Kotorii T. Effects of hCRH on sleep and body temperature rhythms. Psychiatry Clin Neurosci 1995;49:299-304.
15. Born J, Späth-Schwalbe E, Schwakenhofer H, Kern W, Fehm HL. Influences of corticotropin-releasing hormone, adrenocorticotropin, and cortisol on sleep in normal man. J Clin Endocrinol Metab 1989;68:904-11.
16. Kellner M, Yassouridis A, Manz B, Steiger A, Holsboer F, Wiedemann K. Corticotropin-releasing hormone inhibits melatonin secretion in healthy volunteers - a potental link to low-melatonin syndrome in depression? Neuroendocrinology 1997; 16:339-45.
17. Beck-Friis J, Ljunggren JG, Thoren M, Von Rosen D, Kjellman BF, Wetterberg L. Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test. Psychoneuroendocrinology 1985;10:173-86.
18. Miles A, Philbrick DR. Melatonin and psychiatry. Biol Psychiatry 1988;23:405-25.
19. Gillin JC, Jacobs LS, Snyder F, Henkin RI. Effects of ACTH on the sleep of normal subjects and patients with Addison's disease. Neuroendocrinology 1974;15:21-31.
20. Greven HM, De Wied D. The influence of peptides derived from corticotropin (ACTH) on performance. Structure activity studies. Prog Brain Res 1967;37:429-42.
21. Steiger A, Guldner J, Knisatschek H, Rothe B, Lauer C, Holsboer F. Effects of an ACTH/MSH(4-9) analog (HOE 427) on the sleep EEG and nocturnal hormonal secretion in humans. Peptides 1991;12:1007-10.
22. Born J, De Kloet ER, Wenz H, Kern W, Fehm HL. Gluco- and antimineralocorticoid effects on human sleep: a role of central corticosteroid receptors. Am J Physiol 1991;260:E183-8.
23. Friess E, von Bardeleben U, Wiedemann K, Lauer C, Holsboer F. Effects of pulsatile cortisol infusion on sleep-EEG and nocturnal growth hormone release in healthy men. J Sleep Res 1994;3:73-9.
24. Jahn H, Wiedermann K, Steiger A. Effects of metyrapone treatment upon hormonal secretion and sleep. Eur Neuropsychopharmacol 1996; Suppl 3:175.
25. Marrosu F, Gessa GL, Giagheddu M, Fratta W. Corticotropin-releasing factor (CRP) increases paradoxical sleep (PS) rebound in PS-deprived rats. Brain Res 1990;515:315-8.
26. Lauer C, Riemann D, Wiegand M, Berger M. From early to late adulthood. Changes in EEG sleep of depressed patients and healthy volunteers. Biol Psychiatry 1991;29:979-93.
27. Reynolds CF III, Kupfer DJ. Sleep research in affective illness: state of the art circa 1987. Sleep 1987;10:199-215.
28. Rinaman L, Sherman TG, Stricker EM. Vasopressin and oxytocin in the central nervous system. In: Bloom FE, Kupfer DJ, eds. Neuropsychopharmacology. 4th generation of progress. New York: Raven Press, 1995:531-42.
29. Barden N, Reul JM, Holsboer F. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? Trends Neurosci 1995;18:6-11.
30. Timsit-Berthier M, Mantanus H, Devos JE, Spiegel R. Action of lysine-vasopressin on human electroencephalographic activity. Night sleep pattern, auditory evoked potential, contingent negative variation. Neuropsychobiology 1982;8:248-58.
31. Born J, Kellner C, Uthgenannt D, Kern W, Fehm HL. Vasopressin regulates human sleep by reducing rapid-eye-movement sleep. Am J Physiol 1992;262:E295-300.
32. Arnauld E, Bibene V, Meynard J, Rodriguez F, Vincent JD. Effects of chronic icv infusion of vasopressin on sleep-waking cycle of rats. Am J Physiol 1989;256:R674-84.
33. Perras B, Pannenborg H, Marshall L, Pietrowsky R, Born J, Fehm HL. Three months of intranasal vasopressin increased sleep time, slow wave sleep and REM sleep in healthy old humans. Exp Clin Endocrinol Diabetes 1997; Suppl 1:23.
34. Steiger A, Herth T, Holsboer F. Sleep-electroencephalography and the secretion of cortisol and growth hormone in normal controls. Acta Endocrinol (Copenh) 1987;116:36-42.
35. Jarrett DB, Greenhouse JB, Miewald JM, Fedorka IB, Kupfer DJ. A reexamination of the relationship between growth hormone secretion and slow wave sleep using delta wave analysis. Biol Psychiatry 1990;27:497-509.
36. Prinz PN, Weitzman ED, Cunningham GR, Karacan I. Plasma growth hormone during sleep in young and aged men. J Gerontol 1983;38:519-24.
37. Van Coevorden A, Mockel J, Laurent E, et al. Neuroendocrine rhythms and sleep in aging men. Am J Physiol 1991;260: E651-61.
38. Jarrett DB, Kupfer DJ, Miewald JM, Grochocinski VJ, Franz B. Sleep-related growth hormone secretion is persistently suppressed in women with recurrent depression: a preliminary longitudinal analysis. J Psychiatr Res 1994;28:211-23.
39. Jarrett DB, Miewald JM, Kupfer DJ. Recurrent depression is associated with a persistent reduction in sleep-related growth hormone secretion. Arch Gen Psychiatry 1990;47:113-8.
40. Steiger A, von Bardeleben U, Herth T, Holsboer F. Sleep EEG and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before treatment and after recovery. J Affect Disord 1989;16:189-95.
41. Voderholzer U, Laakmann G, Wittmann R, et al. Profiles of spontaneous 24-hour and stimulated growth hormone secretion in male patients with endogenous depression. Psychiatry Res 1993;47:215-27.
42. Beck U, Brezinova V, Hunter WM, Oswald I. Plasma growth hormone and slow wave sleep increase after interruption of sleep. J Clin Endocrinol Metab 1975;40:812-5.
43. Van Cauter E, Kerkhofs M, Caufriez A, Van Onderbergen A, Thorner MO, Copinschi G. A quantitative estimation of growth hormone secretion in normal man: reproducibility and relation to sleep and time of day. J Clin Endocrinol Metab 1992;74: 1441-50.
44. Mullington J, Hermann D, Holsboer F, Pollmacher T. Age-dependent suppression of nocturnal growth hormone levels during sleep deprivation. Neuroendocrinology 1996;64:233-41.
45. Steiger A, Guldner J, Hemmeter U, Rothe B, Wiedemann K, Holsboer F. Effects of growth hormone-releasing hormone and somatostatin on sleep EEG and nocturnal hormone secretion in male controls. Neuroendocrinology 1992;56:566-73.
46. Marshall L, Moelle M, Boeschen G, Steiger A, Fehm HL, Born J. Greater efficacy of episodic than continuous growth hormone releasing hormone (GHRH) administration in promoting slow wave sleep (SWS). J Clin Endocrinol Metab 1996;81: 1009-13.
47. Kern W, Halder R, al-Reda S, Spath-Schwalbe E, Fehm HL, Born J. Systemic growth hormone does not affect human sleep. J Clin Endocrinol Metab 1993;76:1428-32.
48. Garry P, Roussel B, Cohen R, et al. Diurnal administration of human growth hormone-releasing factor does not modify sleep and sleep-related growth hormone secretion in normal young men. Acta Endocrinol (Copenh) 1985;110:158-63.
49. Kupfer DJ, Jarrett DB, Ehlers CL. The effect of GRF on the EEG sleep of normal males. Sleep 1991;14:87-8.
50. Kerkhofs M, Van Cauter E, Van Onderbergen A, Caufriez A, Thorner MO, Copinschi G. Sleep-promoting effects of growth hormone-releasing hormone in normal men. Am J Physiol 1993;264:E594-8.
51. Antonijevic IA, Murck H, Frieboes R-M, Steiger A. Slow wave sleep, but not exogenous GHRH, blunts cortisol and ACTH stimulation by CRH in men. Exp Clin Endocrinol Diabetes 1997; Suppl 1:111.
52. Marshall L, Boes N, Strasburger C, Born J, Fehm HL. Differential influences on sleep of growth-hormone releasing hormone at different concentrations. Exp Clin Endocrinol Diabetes 1997; Suppl 1:113.
53. Schier T, Guldner J, Colla M, Holsboer F, Steiger A. Changes in sleep-endocrine activity after growth hormone-releasing hormone depend on time of administration. J Neuroendocrinol 1997;9:201-5.
54. Steiger A, Guldner J, Colla-Müller M, Friess E, Sonntag A, Schier T. Growth hormone-releasing hormone (GHRH)-induced effects on sleep EEG and nocturnal secretion of growth hormone, cortisol and ACTH in patients with major depression. J Psychiatr Res 1994;28:225-38.
55. Linkowski P, Mendlewicz J, Kerkhofs M, et al. 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. J Clin Endocrinol Metab 1987;65:141-52.
56. Guldner J, Schier T, Friess E, Colla M, Holsboer F, Steiger A. Reduced efficacy of growth hormone-releasing hormone in modulating sleep endocrine activity in the elderly. Neurobiol Aging (in press).
57. Bliwise DL. Sleep in normal aging and dementia. Sleep 1993; 16:40-81.
58. Iovino M, Monteleone P, Steardo L. Repetitive growth hormone-releasing hormone administration restores the attenuated growth hormone (GH) response to GH-releasing hormone testing in normal aging. J Clin Endocrinol Metab 1989;69:910-3.
59. Shibasaki T, Shizume K, Nakahara M, et al. Age-related changes in plasma growth hormone response to growth hormone-releasing factor in man. J Clin Endocrinol Metab 1984; 58:212-4.
60. Murck H, Frieboes R-M, Schier T, Steiger A. Longtime administration of growth hormone-releasing hormone (GHRH) does not restore the reduced efficiency of GHRH on sleep endocrine activity in 2 old-aged subjects - a preliminary study. Pharmacopsychiatry 1997;30:122-4.
61. Danguir J. Intracerebroventricular infusion of somatostatin selectively increases paradoxical sleep in rats. Brain Res 1986; 367:26-30.
62. Beranek L, Obál F Jr, Bodosi B, Taishi P, Laczi F, Krueger JM. Inhibition of non-REM sleep in response to a long-acting somatostatin analogue, sandostatin, in the rat. J Sleep Res 1996; Suppl 1:14.
63. Parker DC, Rossman LG, Siler TM, Rivier J, Yen SS, Guillemin R. Inhibition of the sleep-related peak in physiologic human growth hormone release by somatostatin. J Clin Endocrinol Metab 1974;38:496-9.
64. Kupfer DJ, Jarrett DB, Ehlers CL. The effect of SRIF on the EEG sleep of normal men. Psychoneuroendocrinology 1992; 17:37-43.
65. Frieboes R-M, Murck H, Schier T, Holsboer F, Steiger A. Somatostatin impairs sleep in elderly human subjects. Neuropsychopharmacology 1997;16:339-45.
66. Sonntag WE, Boyd RL, Booze RM. Somatostatinergic gene expression in hypothalamus and cortex of aging male rats. Neurobiol Aging 1990;11:409-16.
67. Bohlhalter S, Murck H, Holsboer F, Steiger A. Cortisol enhances nonREM sleep and growth hormone secretion in elderly subjects. Neurobiol Aging 1997;18:423-9.
68. Mendelson WB, Slater S, Gold P, Gillin JC. The effect of growth hormone administration on human sleep: a dose-response study. Biol Psychiatry 1980;15:613-8.
69. Obál F Jr, Floyd R, Kapás L, Bodos B, Krueger JM. Effects of systemic GHRH on sleep in intact and in hypophysectomized rats. Am J Physiol 1996;270:E230-7.
70. Åström C, Christensen L, Gjerris F, Trojaborg W. Sleep in acromegaly before and after treatment with adenomectomy. Neuroendocrinology 1991;53:328-31.
71. Åström C, Lindholm J. Growth hormone-deficient young adults have decreased deep sleep. Neuroendocrinology 1990; 51:82-4.
72. Ehlers CL, Kupfer DJ. Hypothalamic peptide modulation of EEG sleep in depression: a further application of the S-process hypothesis. Biol Psychiatry 1987;22:513-7.
73. Bredow S, Taishi P, Obál F Jr, Guha-Thakurta N, Krueger JM. Hypothalamic growth hormone-releasing hormone mRNA varies across the day in rat. Neuroreport 1996;7:2501-5.
74. Davidson JR, Moldofsky H, Lue FA. Growth hormone and cortisol secretion in relation to sleep and wakefulness. J Psychiatry Neurosci 1991;16:96-102.
75. Follenius M, Brandenberger G, Bandesapt JJ, Libert JP, Ehrhart J. Nocturnal cortisol release in relation to sleep structure. Sleep 1992;15:21-7.
76. Barbarino A, Corsello SM, Della Casa S, et al. Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man. J Clin Endocrinol Metab 1990;71:1368-74.
77. Bowers CY, Sartor AO, Reynolds GA, Badger TM. On the actions of the growth hormone-releasing hexapeptide, GHRP. Endocrinology 1991;128:2027-35.
78. Copinschi G, Van Onderbergen A, L'Hermite-Baleriaux M, et al. Effects of a 7-day treatment with a novel orally active non-peptide growth hormone secretagogue, MK-677, on 24-hour growth hormone profiles, insulin-like growth factor-I and adrenocortical function in normal young men. J Clin Endocrinol Metab 1996;81:2776-82.
79. Howard AD, Feighner SD, Cully DF, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996;273:974-7.
80. Frieboes R-M, Murck H, Maier P, Schier T, Holsboer F, Steiger A. Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man. Neuroendocrinology 1995;61:584-9.
81. Frieboes R-M, Murck H, Antonijevic IA, Holsboer F, Steiger A. Sleep-endocrinological effects of GH-releasing peptide-6 in man after different routes of application. Exp Clin Endocrinol Diabetes 1997; Suppl 1:1.
82. Kerkhofs M, Van Cauter E, Thorner MO, Copinschi G. Growth hormone (GH), GH-releasing hormone (GHRH). GH-releasing peptide (GHRP) and sleep in man. J Sleep Res 1996; Suppl 1: 107.
83. Davis TM, Burrin JM, Bloom SR. Growth hormone (GH) release in response to GH-releasing hormone in man is 3-fold enhanced by galanin. J Clin Endocrinol Metab 1987;65:1248-52.
84. Toppila J, Stenberg D, Alanko L, et al. REM sleep deprivation induces galanin gene expression in the rat brain. Neurosci Lett 1995;183:171-4.
85. Murck H, Maier P, Frieboes R-M, Schier T, Holsboer F, Steiger A. Galanin promotes REM sleep in man. Pharmacopsychiatry 1995;28:201.
86. Seutin V, Verbanck P, Massotte L, Dresse A. Galanin decreases the activity of locus coeruleus neurons in vitro. Eur J Pharmacol 1989;164:373-6.
87. McCarley RW, Massaquoi SG. Neurobiological structure of the revised limit cycle reciprocal interaction model of REM cycle control. J Sleep Res 1992;1:132-7.
88. Bartfai J. Galanin. A neuropeptide with important central nervous system actions. In: Bloom FE, Kupfer DJ, eds. Neuropsychopharmacology. 4th generation of progress. New York: Raven Press, 1995:563-71.
89. Köhler C, Hallman H, Melander T, Hökfelt T, Norheim E. Autoradiographic mapping of galanin receptors in the monkey brain. J Chem Neuroanat 1989;2:269-84.
90. Aston-Jones G, Bloom FE. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1981;1:876-86.
91. Cespuglio R, Gomez ME, Faradji H, Jouvet M. Alterations in the sleep-waking cycle induced by cooling of the locus coeruleus area. Electroencephalogr Clin Neurophysiol 1982;54: 570-8.
92. McCormick DA, Pape HC, Williamson A. Actions of norepinephrine in the cerebral cortex and thalamus: implications for function of the central noradrenergic system. Prog Brain Res 1991;88:293-305.
93. Valentino RJ, Foote SL, Aston-Jones G. Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res 1983;270:363-7.
94. Monnier M, Hoesli L. Humoral transmission of sleep and wakefulness. II. Hemodialysis of sleep-inducing humor during stimulation of the thalamic hypnogenic area. Pflügers Arch 1965;282:60-75.
95. Graf MV, Kastin AJ. Delta-sleep-inducing peptide (DSIP): a review. Neurosci Biobehav Rev 1984;8:83-93.
96. Borbély AA, Tobler I. Endogenous sleep-promoting substances and sleep regulation. Physiol Rev 1989;69:605-70.
97. Schneider-Helmert D, Schonenberger GA. Effects of DSIP in man. Multifunctional psychophysiological properties besides induction of natural sleep. Neuropsychobiology 1983;9:197-206.
98. Schneider-Helmert D, Graf M, Schönenberger GA. Synthetic delta-sleep-inducing peptide improves sleep in insomniacs. Lancet 1981;1:1256-7.
99. Monti JM, Debellis J, Alterwain P, Pellejero T, Monti D. Study of delta sleep-inducing peptide efficacy in improving sleep on short-term administration to chronic insomniacs. Int J Clin Pharmacol Res 1987;7:105-10.
100. Bes F, Hofman W, Schuur J, Van Boxtel C. Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study. Neuropsychobiology 1992;26:193-7.
101. Feldman SC, Kastin AJ. Localization of neurons containing immunoreactive delta sleep-inducing peptide in the rat brain: an immunocytochemical study. Neuroscience 1984;11:303-17.
102. Friedman TC, Garcia-Borreguero D, Hardwick D, et al. Decreased delta-sleep and plasma delta-sleep-inducing peptide in patients with Cushing syndrome. Neuroendocrinology 1994; 60:626-34.
103. Van Kammen DP, Widerlöv E, Neylan TC, et al. Delta sleep-inducing-peptide-like immunoreactivity (DSIP-LI) and delta sleep in schizophrenic volunteers. Sleep 1992;15:519-25.
104. Seifritz E, Müller MJ, Schönenberger GA, et al. Human plasma DSIP decreases at the initiation of sleep at different circadian times. Peptides 1995;16:1475-81.
105. Bohlhalter S, Antonijevic IA, Brabant G, Holsboer F, Steiger A. Short term pulsatile administration of neuropeptide Y suppresses ACTH and cortisol secretion, promotes sleep, but does not affect leptin secretion in man. Exp Clin Endocrinol Diabetes 1997; Suppl 1:111.
106. Copinschi G, Van Onderbergen A, L'Hermite-Baleriaux M, et al. Effects of the short-acting benzodiazepine triazolam, taken at bedtime, on circadian and sleep-related hormonal profiles in normal men. Sleep 1990;13:232-44.
107. Steiger A, Guldner J, Lauer C, Meschenmoser C, Pollmächer T, Holsboer F. Flumazenil exerts intrinsic activity on sleep EEG and nocturnal hormone secretion in normal controls. Psychopharmacology 1994;113:334-8.
108. Ehlers CL, Somes C, Lopez A, Kirby D, Rivier JE. Electrophysiological actions of neuropeptide Y and its analogs: new measures for anxiolytic therapy? Neuropsychopharmacology 1997;17:34-43.
109. Heilig M, Koob GF, Ekman R, Britton KT. Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci 1994;17:80-5.
110. Stenzel-Poore MP, Heinrichs SC, Rivest S, Koob GF, Vale WW. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J Neurosci 1994;14:2579-84.
111. Skutella T, Criswell H, Moy S, et al. Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat. Neuroreport 1994;5:2181-5.
112. Liebsch G, Landgraf R, Gerstberger R, et al. Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul Pept 1995;59:229-39.
113. Owens MJ. Bissette G, Nemeroff CB. Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain. Synapse 1989;4:196-202.
114. Hemmeter U, Steiger A, Guldner J, Rothe B, Holsboer F. Effects of TRH on sleep EEG and nocturnal release of growth hormone and cortisol. Pharmacopsychiatry 1992;25:104.
115. Smith GP, Jerome C, Cushin BJ, Eterno R, Simansky KJ. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 1981;213:1036-7.
116. Antin J, Gibbs J, Holt J, Young RC, Smith GP. Cholecystokinin elicits the complete behavioral sequence of satiety in rats. J Comp Physiol Psycho! 1975;89:784-90.
117. DeMesquita S, Haney WH. Effect of chronic intracerebroventricular infusion of cholecystokinin on respiration and sleep. Brain Res 1986;378:127-32.
118. Watanabe N, Sakai T, Tada K, Masuno J, Moroji T. The effects of caerulein on nocturnal sleep. Prog Neuropsychopharmacol Biol Psychiatry 1986;10:749-54.
119. Pietrowsky R, Fehm HL, Er A, Bathelt B, Born J. Influences of the cholecystokinin analog ceruletide on human sleep and evoked potentials. Neuropsychobiology 1990;23:41-7.
120. de Montigny C. Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Arch Gen Psychiatry 1989; 46:511-7.
121. Drucker-Colin R, Bernal-Pedraza J, Fernandez-Cancino F, Oksenberg A. Is vasoactive intestinal polypeptide (VIP) a sleep factor? Peptides 1984;5:837-40.
122. Obál F Jr, Payne L, Kacsoh B, et al. Involvement of prolactin in the REM sleep-promoting activity of systemic vasoactive intestinal peptide (VIP). Brain Res 1994;645:143-9.
123. Riou F, Cespuglio R, Jouvet M. Endogenous peptides and sleep in the rat. III. The hypnogenic properties of vasoactive intestinal polypeptide. Neuropeptides 1982;2:265-77.
124. Murck H, Guldner J, Frieboes R-M, et al. VIP decelerates non-REM-REM cycles and modulates hormone secretion during sleep in men. Am J Physiol 1996;271:R905-11.
125. Van den Pol AN, Tsujimoto KL. Neurotransmitters of the hypothalamic suprachiasmatic nucleus: immunocytochemical analysis of 25 neuronal antigens. Neuroscience 1985;15:1049-86.
126. Besson J, Sarrieau A, Vial M, Marie JC, Rosselin G, Rostene W. Characterization and autoradiographic distribution of vasoactive intestinal peptide binding sites in the rat central nervous system. Brain Res 1986;398:329-36.
127. Morin AJ, Denoroy L, Jouvet M. Daily variations in concentration of vasoactive intestinal peptide immunoreactivity in hypothalamic nuclei of rats rendered diurnal by restricted-schedule feeding. Neurosci Lett 1993;152:121-4.
128. Albers HE, Liou SY, Stopa EG, Zoeller RT. Neurotransmitter colocalization and circadian rhythms. Prog Brain Res 1992;92: 289-307.
129. Rolandi E, Franceshini R, Cataldi A, Barreca T. Twenty-four-hour secretory pattern of vasoactive intestinal polypeptide in the elderly. Gerontology 1990;36:356-60.
130. Chee CA, Roozendaal B, Swaab DF, Goudsmit E, Mirmiran M. Vasoactive intestinal polypeptide neuron changes in the senile rat suprachiasmatic nucleus. Neurobiol Aging 1988;9:307-12.
131. Swaab DF. Brain aging and Alzheimer's disease, "wear and tear" versus "use it or lose it". Neurobiol Aging 1991;12:317-24.
132. Witting W, Mirmiran M, Bos NP, Swaab DF. Effect of light intensity on diurnal sleep-wake distribution in young and old rats. Brain Res Bull 1993;30:157-62.
133. Van Someren EJ, Mirmiran M, Swaab DF. Non-pharmacological treatment of sleep and wake disturbances in aging and Alzheimer's disease: chronobiological perspectives. Behav Brain Res 1993;57:235-53.
134. Kastin AJ, Coy DH, Schally AV, Miller LH. Peripheral administration of hypothalamic peptides results in CNS changes. Pharmacol Res Commun 1978;10:293-312.
135. Begley DJ. Peptides and the blood-brain barrier: the status of our understanding. Ann NY Acad Sci 1994;739:89-100.
136. Terasaki T, Takakuwa S, Saheki A, et al. Absorptive-mediated endocytosis of an adrenocorticotropic hormone (ACTH) analogue, ebiratide, into the blood-brain barrier: studies with monolayers of primary cultured bovine brain capillary endothelial cells. Pharm Res 1992;9:529-34.
137. Drewe J, Fricker G, Behrens U, Gutmann H, Beglinger C, Huwyler J. Are peripheral gut hormones able to cross the blood-brain barrier? Naunyn Schmiedebergs Arch Pharmacol 1997;355:R106.
138. Broadwell RD, Sofroniew MV. Serum proteins bypass the blood-brain fluid barriers for extracellular entry to the central nervous system. Exp Neurol 1993;120:245-63.
139. Friess E, Wiedemann K, Steiger A, Holsboer F. The hypothalamic-pituitary-adrenocortical system and sleep in man. Adv Neuroimmunol 1995;5:111-25.
140. Dickson SL, Luckman SM. Indication of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6. Endocrinology 1997;138:771-7.
141. Korbonits M, Forsling ML, Trainer PJ, Besser GM, Grossman AB. Growth hormone secretagogues (GHRP-6, hexarelin and the non-peptide analogue L-692,419) stimulate the release of arginine-vasopressin from the rat hypothalamus in vitro. 22nd International Symposium Growth Hormone and Growth Factors in Endcrinology and Metabolism, Vienna, 1996;111.